Altisource Releases Annual Report on the State of the Originations Industry
LUXEMBOURG, Feb. 20, 2020 (GLOBE NEWSWIRE) — Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider of […]
Obalon Announces Opening of Second Retail Treatment Center in Orange County, CA
SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated weight loss solutions company […]
Novan Receives Phase 2 NIH Federal Grant of Approximately $1.0 Million
Provides funds to evaluate the mechanistic antiviral activity of WH602Novan to progress IND-enabling toxicology and pharmacology studies for WH602Grant is […]
Monster Beverage to Report 2019 Fourth Quarter Financial Results on February 27, 2020
CORONA, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ:MNST) announced today that results for its fourth quarter […]
Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the […]
ManTech Launches “Career Enablement” to Accelerate Employee Advancement
HERNDON, Va., Feb. 20, 2020 (GLOBE NEWSWIRE) — ManTech (Nasdaq: MANT) today launches a new “Career Enablement” program that will […]
resTORbio to Present at the 9th Annual Leerink Partners Global Healthcare Conference
BOSTON, Feb. 20, 2020 (GLOBE NEWSWIRE) — resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target […]
Alimera Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020 and Provide Corporate Update
ATLANTA, Feb. 20, 2020 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development […]
miRagen Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on March 11, 2020
BOULDER, Colo., Feb. 20, 2020 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the […]
Genocea to Present at the SVB Leerink 9th Annual Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, […]
